MAR 07 2023 News Releases Otsuka Medical Devices appoints Board Members and Audit & Supervisory Board Members
FEB 28 2023 News Releases Announces Two Concurrent JAMA Network Publications of Study Results on the Paradise Ultrasound Renal Denervation System for the Treatment of Hypertension (Link to ReCor website)
FEB 22 2023 Information Donations to Support Relief Efforts Following Earthquakes in Turkey and Syria (Link to Otsuka Pharmaceutical website)
JAN 03 2023 News Releases ReCor Medical Names Lara Barghout President and Chief Executive Officer (Link to ReCor website)
DEC 26 2022 News Releases Otsuka Medical Devices has entered into an exclusive agreement with CSI to distribute Diamondback 360®Coronary Orbital Atherectomy System in Japan
DEC 13 2022 Information Otsuka Group Selected for CDP Climate Change A List (Link to Otsuka Holdings website)
NOV 30 2022 News Releases Submission of Application for Pre-Market Approval of the Paradise™ Ultrasound Renal Denervation (uRDN) System to the U.S. Food and Drug Administration
NOV 07 2022 News Releases Announced Consistent Reduction of Blood Pressure in Pooled Analysis of Three Clinical Trials at AHA 2022
NOV 02 2022 News Releases Veryan Medical announces the 36-month Outcomes for the BioMimics 3D Stent in Longer Lesions: A Subgroup Analysis of the MIMICS-3D EU Registry were presented at VIVA 22 (Link to Veryan website)